Our Team
We‘re experts in navigating the medtech sector. We specialise across the full spectrum of therapeutic areas, medical devices and biologics.
Our experience as former PBS and MBS submission evaluators sets us apart. This background gives us unparalleled insight into how evidence is reviewed and assessed.
Our team’s diversity brings together a wide range of perspectives and experiences, fostering innovative thinking and tailored solutions. This enables us to deliver more insightful, adaptable strategies that drive superior outcomes.
Managing Director
Oona Reardon is a healthcare economist with more than 20 years of experience across private, public and academic settings, specialising in market access, health economics and evidence evaluation. She is one of the few consultants in Australia with direct experience as a PBS and MBS submission evaluator, giving her a deep understanding of how reimbursement evidence is reviewed, critiqued and ultimately assessed. This evaluator perspective underpins Pulse Economics’ approach and sets it apart in the market access landscape….[read more]
Associate Director
Carol Lee is a specialist in strategy development and clinical review for PBAC and MSAC reimbursement submissions. With an impressive tenure of over two decades in her field, Carol brings a wealth of expertise spanning various therapeutic areas, including cardiology, endocrinology, neurology, and oncology.
Throughout her career, Carol has developed many public reimbursement submissions and has particular expertise in literature reviews, clinical trial evaluations…[read more]
Associate Director
Dr Michael Ortiz is an expert in value-based pricing, reimbursement, product life cycle management and economic and budget impact modelling. With over two decades of global experience, Michael has excelled in pivotal roles, managing market access teams at pharmaceutical companies of various sizes and portfolios worldwide. Michael’s commitment to the pharmaceutical landscape extends to his active involvement in several Medicines Australia national committees…[read more]
Associate Director
At Pulse Economics, Dr. Roy Ramiscal leverages his expertise in early-stage business model development, investment due diligence, market access, and financial and economic modelling to help clients grow their business. Roy has advised clients across the public sector, not-for-profit organisations, ASX-listed companies, and early-stage ventures. He helps clients with PBS and MBS listings and previously worked on advising the Australian Government MSAC…[read more]
Manager
Lisa Barrett specialises in health outcomes research, an essential component to support economic evaluation. With an impressive 15 years of experience across various healthcare sectors, including clinical research and hospital and outpatient settings, Lisa brings a wealth of practical knowledge to her role.
Lisa’s proficiency extends to conducting clinician surveys and fostering essential collaborations between health economists, clinicians, patient advocacy groups, and government authorities…[read more]
Our deep industry engagement sets us apart. We’re proud members of leading professional associations and networks, locally and globally.
We’re not just management consultants at Pulse Economics; we’re catalysts for your success in the evolving healthcare innovation landscape.
Get in touch with us to discover how we can help you achieve your goals.
